PT-141 reconstitution calculator.
A 10 mg vial of PT-141 dissolved in 2 mL of bacteriostatic water is 5,000 mcg per mL, which is 50 mcg per unit on a U-100 insulin syringe.
PT-141 is bremelanotide, approved as Vyleesi in a fixed single-use autoinjector that needs no mixing. Research vials are typically 10 mg, which is a large mass against targets discussed in the low milligrams.
Reference range often cited for PT-141: 1000–2000 mcg, shown for orientation only, not a recommendation. Enter your own target below. Read the evidence →
Each unit on a 100u · 1.0 mL syringe ≈ 50 mcg of this solution.
Show the math
More water → lower concentration → more units for the same amount.
How much bacteriostatic water for a PT-141 vial?
There is no single correct volume. More water gives a weaker solution, so each unit on the syringe holds less PT-141 and a given amount takes more units to measure, which is easier to read on the syringe scale. Less water does the opposite. These tables show the concentration for each common vial size across the usual volumes. They are arithmetic, not a recommendation of how much to take.
| BAC water | Concentration | Per 1 unit | Per 10 units |
|---|---|---|---|
| 1 mL | 10,000 mcg/mL | 100 mcg | 1,000 mcg |
| 1.5 mL | 6,667 mcg/mL | 66.7 mcg | 667 mcg |
| 2 mL | 5,000 mcg/mL | 50 mcg | 500 mcg |
| 2.5 mL | 4,000 mcg/mL | 40 mcg | 400 mcg |
| 3 mL | 3,333 mcg/mL | 33.3 mcg | 333 mcg |
How many units of PT-141 is a given amount?
Divide the amount in micrograms by the micrograms per unit for your mix. With a solution of 2,500 mcg per mL, one unit on a U-100 syringe holds 25 mcg, so any amount in mcg divided by 25 gives the units. The calculator above does this for you from your own vial and water, and the tables give the per-unit figure for each common mix.
New to this? The step-by-step tutorials cover mixing a vial and reading a U-100 syringe, with diagrams.
Why does PT-141 need its own calculation?
- 10 mg in 2 mL is 5,000 mcg/mL, so 1 mg is 20 units and 2 mg is 40 units.
- The approved autoinjector delivers a fixed amount by design. A vial gives you an arbitrary concentration instead, which is precisely why the arithmetic matters.
- A 10 mg vial holds many draws at milligram scale, so the reconstituted stability window is usually the limit rather than the peptide running out.
How is PT-141 administered, and what does the math look like?
How PT-141 is actually administered, with the concentration arithmetic written out. Amounts in these tables are illustrative examples of the math, never a recommendation.
PT-141: research formats
Choose the format you are researching to see route-specific notes.
Vyleesi is an FDA-approved auto-injector; research use from 10 mg vials also exists.
PT-141 (bremelanotide) is FDA-approved as Vyleesi (1.75 mg/0.3 mL auto-injector) for hypoactive sexual desire disorder in premenopausal women. Research contexts also use lyophilized 10 mg vials reconstituted with BAC water.
Research-use vials: 10 mg + 2.0 mL BAC water = 5,000 mcg/mL. At this concentration, 250–500 mcg = 5–10 units on a U-100 syringe.
The FDA label for Vyleesi specifies SC administration in the abdomen or thigh, at least 45 minutes before anticipated sexual activity. No more than one dose per 24 hours.
PT-141 reconstitution: common questions
Is Vyleesi the same as a PT-141 vial?
Same molecule, different presentation. Vyleesi is an FDA-approved single-use autoinjector with a fixed labeled amount. A lyophilized vial has no label governing it and a concentration you set yourself.
How many units is 1.75 mg of PT-141?
On 10 mg in 2 mL (5,000 mcg/mL), 1.75 mg is 1,750 mcg, which is 35 units. Change the water volume and that figure moves proportionally.
Why is my draw so small?
A 10 mg vial in a small volume is concentrated. If a target lands in the first few units, adding water spreads the same amount across more of the barrel and makes it readable.
What the evidence on PT-141 actually shows
Knowing the concentration is not the same as knowing whether to use it. These are the strongest studies behind the PT-141 profile, labelled with the study type PubMed itself assigns.
- Systematic review / meta-analysis · 2021Re-Analyzing Phase III Bremelanotide Trials for "Hypoactive Sexual Desire Disorder" in WomenJournal of sex research · PMID 33678061
- Randomized controlled trial · 2019Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 TrialsObstetrics and gynecology · PMID 31599840
- Journal article · 2019Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire DisorderObstetrics and gynecology · PMID 31599847
This page is arithmetic on numbers you enter. It does not recommend an amount of PT-141, and nothing here is medical advice. For what the published evidence actually supports, read the PT-141 profile, and for regulatory status see is PT-141 legal. Reviewed June 1, 2026.
Different question? The general reconstitution calculator covers every compound on the site, the blend calculator handles multi-peptide stacks, and vial longevity turns a vial into weeks of supply.
PepCue remembers your PT-141 vial, concentration, and draw, then tracks every dose against it. Free.